BC
ELV icon

Brookfield Corp’s Elevance Health ELV Stock Holding History

Brookfield Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-501
Closed -$223K – 244
2023
Q2 		$223K Sell
501
-3,674
-88% -$1.69M ﹤0.01% 570
2023
Q1 		$1.92M Buy
+4,175
New +$1.99M 0.01% 424
2022
Q1 		– Sell
-1,501
Closed -$696K – 672
2021
Q4 		$696K Buy
+1,501
New +$631K ﹤0.01% 508
2020
Q4 		– Sell
-7,270
Closed -$1.95M – 468
2020
Q3 		$1.95M Sell
7,270
-5,378
-43% -$1.45M 0.01% 247
2020
Q2 		$3.33M Buy
+12,648
New +$3.37M 0.02% 175

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Brookfield Corp's ELV Position: Q3 2023 in Review

Brookfield Corp sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 501 shares — an estimated $223K sold.

Brookfield Corp first reported a position in ELV in Q2 2020 and held it in 5 quarters. The position peaked at $3.33M in Q2 2020. 1,525 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Brookfield Corp reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 501 Elevance Health shares in Q3 2023, an estimated $223K.
  • Brookfield Corp first reported a position in Elevance Health in Q2 2020 and held it in 5 quarters.
  • Brookfield Corp's Elevance Health position peaked at $3.33M in Q2 2020.
  • 1,525 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.